Topical ciprofloxacin can delay recovery from viral ocular surface infection.
Patwardhan
A
A
Department of Ophthalmology, Royal Shrewsbury Hospital, Mytton Oak Road, Shrewsbury SY3 8XQ, UK. apatwa@hotmail.com
Khan
M
M
D000257:Adenoviridae Infections / Q000188:drug therapy*; D000287:Administration, Topical; D000890:Anti-Infective Agents / Q000009:adverse effects*; D002939:Ciprofloxacin / Q000009:adverse effects*; D003316:Corneal Diseases / Q000139:chemically induced*; D015828:Eye Infections, Viral / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007639:Keratoconjunctivitis, Infectious / Q000188:drug therapy*; D008297:Male; D009883:Ophthalmic Solutions / Q000009:adverse effects; D014786:Vision Disorders / Q000139:chemically induced; D014792:Visual Acuity
D000890:Anti-Infective Agents; D009883:Ophthalmic Solutions; D002939:Ciprofloxacin